ENERGENESIS (6657) Monthly Revenue

Market: TWSE-listed · Industry: Biotech & Medical · 華安

ENERGENESIS (6657) reported revenue of NT$386,000 for Oct 2026, -66.1% year on year and -11.1% from the previous month. Revenue for Jan–Oct 2026 was NT$5.5 million (-8.6% year on year).

In Oct 2026, it ranked No. 150 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$882,00024/10Nov 2024 NT$1.1 millionDec 2024 NT$600,000Jan 2025 NT$432,000Feb 2025 NT$295,00025/02Mar 2025 NT$486,000Apr 2025 NT$426,000May 2025 NT$713,000Jun 2025 NT$925,00025/06Jul 2025 NT$493,000Aug 2025 NT$317,000Sep 2025 NT$772,000Oct 2025 NT$1.1 million25/10Nov 2025 NT$555,000Dec 2025 NT$1.1 millionJan 2026 NT$391,000Feb 2026 NT$270,00026/02Mar 2026 NT$730,000Apr 2026 NT$809,000May 2026 NT$541,000Jun 2026 NT$502,00026/06Jul 2026 NT$614,000Aug 2026 NT$803,000Sep 2026 NT$434,000Oct 2026 NT$386,00026/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$386,000-66.1%-11.1%
Sep 2026NT$434,000-43.8%-46.0%
Aug 2026NT$803,000+153.3%+30.8%
Jul 2026NT$614,000+24.5%+22.3%
Jun 2026NT$502,000-45.7%-7.2%
May 2026NT$541,000-24.1%-33.1%
Apr 2026NT$809,000+89.9%+10.8%
Mar 2026NT$730,000+50.2%+170.4%
Feb 2026NT$270,000-8.5%-30.9%
Jan 2026NT$391,000-9.5%-65.1%
Dec 2025NT$1.1 million+86.8%+102.0%
Nov 2025NT$555,000-50.2%-51.3%
Oct 2025NT$1.1 million+29.1%+47.5%
Sep 2025NT$772,000+69.7%+143.5%
Aug 2025NT$317,000-69.8%-35.7%
Jul 2025NT$493,000-19.2%-46.7%
Jun 2025NT$925,000+174.5%+29.7%
May 2025NT$713,000-8.2%+67.4%
Apr 2025NT$426,000-17.4%-12.3%
Mar 2025NT$486,000-35.3%+64.7%
Feb 2025NT$295,000+22.4%-31.7%
Jan 2025NT$432,000+3.8%-28.0%
Dec 2024NT$600,000-2.4%-46.1%
Nov 2024NT$1.1 million+10.8%+26.3%
Oct 2024NT$882,000+43.4%+93.8%

Jan–Oct 2026 cumulative: NT$5.5 million (-8.6% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: ENERGENESIS vs PEC / ENERGENESIS vs Lotus Pharm / ENERGENESIS vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

Company remark (original Chinese)

主要係試劑銷售及勞務收入皆減少

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16